Suven Life Sciences Ltd’s net profit decreased 48 per cent at ₹17 crore in the fourth quarter ended March 31, compared to ₹32.4 crore in the corresponding quarter of previous year.
The total revenue of the Hyderabad-based company also took a hit, decreasing by 13 per cent to ₹114.5 crore (₹132 crore).
For the full year ended March 31, its profit declined by 25 per cent to ₹109 crore (₹144 crore) on a revenue of ₹529 crore (₹513 crore), according to a release.
The board has approved a dividend of ₹0.60 per share subject to the approval of shareholders.
The company’s scrip fell 6.80 per cent to end at ₹267.35 on the Bombay Stock Exchange on Wednesday.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.